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For many years, it was thought that sequencing the human genome would hold the answer to health and dis-
ease. However, after years of research and billions of dollars of funding, the Human Genome Project provided 
us with the script for the human genome, but not the great leap in understanding for genetic medicine that was 
anticipated. We still have many questions, particularly how the genome interacts with the environment to result 
in disease in some individuals, but not in others. For this we need to focus on the epigenome. In the 1940s, 
the epigenetic landscape began to take shape; famously described by Waddington [1], it explained how cells 
with the same genetic code could differentiate into the vast array of cells within an organism, connecting the 
genotype with the phenotype. The field of ‘epigenetics’, literally meaning ‘above genetics’, investigates chemical 
modifications to DNA that do not alter the gene sequence itself [2]. Epigenetic mechanisms, such as chromatin 
remodeling, histone modifications, DNA methylation and microRNAs, alter how the genome is expressed. These 
modifications can be enduring and passed through generations, but they can also be transient, allowing cells to 
adapt to the environment. In recent years, there has been an exponential increase in the research and knowledge 
within the field of epigenetics. It is only now that we are beginning to piece together interactions between the 
genome and epigenome with the environment to comprehend the implications for health and disease. A key 
environmental factor that we are exposed to from preconception to death is our diet. Nutri-epigenomics looks to 
delineate the interactions between the diet and the genome through epigenetic mechanisms.
The susceptibility of the epigenome to adapt to environmental factors alters across the lifespan of an organ-
ism, during which there are periods when the epigenome is more responsive to change [3]. Increased activity of 
the epigenome occurs in the prenatal and neonatal phases when cell differentiation and specialization is occur-
ring. Environmental factors, such as nutrition, therefore have more influence during this period of development. 
In nature this mechanism is utilized by the honeybee, they feed genetically identical larvae royal jelly to alter 
DNA methylation patterns with the result of differentiation to either a queen or a worker bee [4]. In humans, the 
Developmental Origins of Health and Disease hypothesis explains how abnormalities within the developmental 
environment can affect the writing of the epigenome and lead to metabolic disease later in life [5]. It is under-
stood that maternal stress, birth weight and fetal malnutrition (undernutrition and maternal obesity) contribute 
to an abnormal developmental environment and modifications to the epigenome, and as a result, can be endur-
ing throughout the lifespan and passed on to the next generation. In mammals, malnutrition of methyl donors 
vitamin B
12
 and choline during gestation can lead to epigenetic dysregulation within the offspring, leading to 
obesity and influencing disease in later life [6]. Providing a favorable developmental environment through the use 
of nutritional supplements or a specific gestational diet could result in beneficial epigenetic changes. For example, 
“Nutri-epigenomics looks to delineate the interactions 
between the diet and the genome through epigenetic 
mechanisms.”
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supplementation with omega-3 fatty acids during gestation has been shown to protect against demethylation 
caused by the negative behavior of smoking [7]. Looking to the future, is developing an ‘epigenetically healthy’ 
gestational diet the answer to reducing the burden of chronic disease in later life and within our offspring? Future 
research must consider the hereditary nature of epigenetic signatures, with studies requiring observation of mul-
tiple generations. There must also be consideration for the long-term epigenetic impact of in vitro fertilization 
(IVF), where the early stages of development receive nutrients from outside of the mother.
Convincing individuals to maintain an ‘epigenetically healthy’ diet in order to benefit the health of their chil-
dren and grandchildren is often not effective as there is no immediate beneficial effect seen by the individual. 
Therefore, research into the short-term effects of diet on the epigenome is required in adults. Aberrant alterations 
to epigenetic regulation is implicated as the cause of multiple chronic diseases including cancer, chronic obstruc-
tive pulmonary disease, cardiovascular disease, obesity, neurological disorders and Type-2 diabetes, to name a 
few. These changes in the epigenome provide therapeutic targets for intervention. Drugs have been developed to 
target epigenetic regulating enzymes, such as DNMT, HDAC and HAT inhibitors in order to reverse the changes 
to the epigenome. Discussed in a mini-review series in Clinical Epigenetics [8], there is a huge potential for epigen-
etic drugs; however, there is a long way to go before we truly understand their impact, particularly their wider 
alterations to the epigenome. Nutritional interventions or dietary supplementation may therefore provide a safer 
approach to prevent or reset these aberrant changes by influencing the natural epigenetic response within cells.
Personalized medicine and interventions are now common with the use of genotyping an individual in order 
to distinguish if they are a responder or a nonresponder to drugs and nutritional interventions. There has also 
been an increase in the use of genetic testing to identify targeted populations and interventions that will reduce 
the burden of disease in later life [9]. However, there is building evidence that epigenetic signatures could also be 
used to personalize interventions and predict response status. For example, it has been found that determining 
an ‘epigenotype’ for an individual can predict whether they are going to be a weight-loss responder to a calorie 
restricted diet [10]. We therefore must also consider the effect of the epigenome on nutritional requirements. Data 
such as this may be used to combine both genotype and epigenotype of an individual to assess their risk status 
for disease and response to nutritional interventions.
Implementation of epigenetic analysis to nutritional studies has barriers that must be considered, including 
technical and cost limitations. Careful consideration must be taken when choosing the sample for epigenetic 
analysis. Epigenetic control of the genome is cell specific and conversely, this means that alterations in response 
to the environment will be individual to tissue type and to individual cells within the tissue. Therefore, selecting 
an easily accessible tissue such as blood for analysis may lead to misleading findings due to the heterogeneity of 
cells and care must be taken when inferring conclusions from the sample tissue to the desired tissue of interest. 
Additionally the tissue composition must be accounted for, changes to tissue composition as a result of an inter-
vention may lead to critical results being masked or exaggerated without specificity to one cell type or adjust-
ment for any change [11]. Establishing causation is often an issue in epigenetic research, although there have been 
statistical methods employed to delineate causation [12], and carefully designed and controlled research is vital. 
Considerations into the biological relevance of statistically significant results must be supported by phenotypic 
data such as gene expression and protein profiles. Epigenetic control of the genome is far more complicated than 
first thought with a multitude of different epigenetic mechanisms to quantify, plus their interactions with each 
other. For example, considering DNA methylation alone, there are multiple modifications in the chemistry 
to cytosine other than the heavily studied methylcytosine, including hydroxymethylcytosine, formylcytosine 
and carboxycytosine, that cannot currently be resolved through the bisulfite sequencing methods. Methods to 
quantify these other cytosine modifications are being developed but currently not concordant with each other 
or available for whole genome use [13]. Due to the complexity of the epigenome, many of the technologies used 
to measure its epigenetic makeup come at a high cost. Institutions and funding bodies must ‘buy in’ to running 
these high cost assays in order to gain additional information from their nutritional research.
Conclusion
Given the interactions between nutrition and the epigenome, future work in this field has the potential to provide 
a rewarding benefit for public health. If we want to understand how our body responds to nutritional interven-
tions then we need to understand the interactions with the genome and epigenome. Understanding these modifi-
cations, which can be passed through generations, will provide vital knowledge to thwarting noncommunicable 
diseases and promoting healthy free living in later life. We have the potential to impact on the evolution of the 
human species by tailoring our diets to alter/maintain the epigenome.
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